Samuel So on ending viral hepatitis
A Stanford liver disease expert and leading anti-hepatitis campaigner recently discussed what it will take to rub out viral hepatitis and why it’s important. Hint: It causes more than 20,000 U.S. deaths annually.
Almond discusses trial of kids’ heart pump
Stanford is leading a multisite study of a new ventricular assist device for children who are awaiting heart transplantation. The miniature pump is slightly bigger than a paper clip.
Adelsheim on CDC’s youth suicide report
The recent federal report on suicides among youth in Santa Clara County will inform how the community continues to support mental health for young people, said Stanford psychiatrist Steven Adelsheim.
Clues to why severe dengue affects some
A new study has found a specific immunologic response among people likely to get severe dengue disease. The work could help lead to a screening test for people at risk of getting a serious case of the disease and to targeted vaccines.
Researcher loafs around
Fiona Strouts began baking bread as a hobby. Now, she sells her homemade loaves at the Portola Valley Farmers Market.
Owens on new statin recommendation
The Stanford professor of medicine was a member of the U.S. Preventive Services Task Force, which has issued a new recommendation on statin use based on an extensive literature review.
Kim discusses Biohub infectious disease project
The Chan Zuckerberg Biohub will include two major research projects intended to help cure and prevent disease. One, focusing on infectious disease, will be led by biochemist Peter Kim.
Teen beliefs about marijuana
A survey of hundreds of California high-school students shows that teens don’t understand the risks of marijuana use, and are more likely to smoke it if they have seen marijuana ads.
Darnall on opioids and pain management
A Stanford Medicine psychologist is helping patients reduce pain without opioids and prescription drugs. She offers practical steps for people to harness the power of their mind-body connection to reduce symptoms of pain and increase their quality of life.
Malenka calls for MDMA research
In a Q&A, the neuroscientist discusses the reasons for continued basic and clinical research on an illegal drug scientists call 3,4-methylenedioxymethamphetamine, or MDMA, and partiers call Ecstasy.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.